Compare MRVI & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | FEIM |
|---|---|---|
| Founded | 2014 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.8M | 439.6M |
| IPO Year | 2020 | 1994 |
| Metric | MRVI | FEIM |
|---|---|---|
| Price | $2.86 | $42.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $4.13 | ★ $42.50 |
| AVG Volume (30 Days) | ★ 1.7M | 183.8K |
| Earning Date | 05-11-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 316.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $185,743,000.00 | $69,811,000.00 |
| Revenue This Year | $12.44 | N/A |
| Revenue Next Year | $7.90 | $21.73 |
| P/E Ratio | ★ N/A | $105.93 |
| Revenue Growth | N/A | ★ 26.30 |
| 52 Week Low | $1.67 | $14.41 |
| 52 Week High | $4.11 | $61.47 |
| Indicator | MRVI | FEIM |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 41.73 |
| Support Level | $2.57 | $41.78 |
| Resistance Level | $2.88 | $59.68 |
| Average True Range (ATR) | 0.17 | 4.29 |
| MACD | -0.04 | -0.37 |
| Stochastic Oscillator | 4.73 | 13.74 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.